ONWARD Medical to Announce First Quarter 2026 Results
ONWARD Medical NV will release its first quarter 2026 financial results and host a webcast on May 26, 2026, presented by CEO Dave Marver. The company is focused on developing neurotechnology therapies for spinal cord injuries and has received multiple FDA Breakthrough Device Designations.
EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its first quarter 2026 financial results and host a webcast to provide a comprehensive business update on May 26, 2026.